Any current/future capex/capital investment/strategic investment?

The company plans to invest in expanding biobased specialty chemicals capacities, with some capacity increases expected from Q4 2025 onwards. There is a strategic focus on developing a grain-based ethanol facility to add dual feedstock capability, providing flexibility and mitigating climate risk. Current CAPEX for the grain-based ethanol project is under assessment, with a stronger update expected in the next quarter. The IPO proceeds are being used primarily to reduce debt, thereby freeing up internal accruals and cash flow for these growth investments. Investments will support participation

Future growth expectations in sales/revenue/volumes?

The company anticipates a better sugarcane crushing season from November 2024 to April 2025 due to favorable monsoon and restored ethanol blending program, leading to higher volumes and revenue in H2 FY25. Revenue growth was 34% YoY in Q2 FY25 and 25% in H1 FY25 despite seasonality; a stronger performance and improved profitability are expected in H2 FY25 due to crushing season commencement. Expansion plans include increasing capacities in biobased specialty chemicals starting Q4 2025, driven by strong global demand and co-creation with customers for decarbonization. Investment in grain-

Future growth expectations in earnings/operating earnings/profits/EPS?

Company expects significant improvement in H2 FY25 results due to commencement of sugarcane crushing from November 2024 and restoration of ethanol blending program, leading to higher production and revenue. EBITDA and profitability traditionally stronger in H2; last 3 years showed H2 EBITDA over 100% of full-year EBITDA. Investment focus on biobased chemicals expansion starting Q4 2025, aiming to improve segment profitability and ROCE. Debt reduction via IPO proceeds will save approx. Rs. 24-25 crores annually in interest, freeing cash flow for growth investments. Grain-based ethanol facility

Current/ Expected Orderbook/ Pending Orders?

For ethanol bidding under government tenders, Godavari Biorefineries bid for over 10 crore liters but was allotted about 7.5 crore liters (5.4 crore liters for juice-based ethanol and 2.5 crore liters for B-heavy molasses). No bids have been placed yet for grain-based ethanol as the company is still in the process of creating that capacity. The company expects increased demand for biobased specialty chemicals in the second half of FY25, leading to capacity expansions starting Q4 FY25. There is a strong funnel of product development projects with customers for biobased chemicals, with many earl

IN US

Sale is live|00:00:00left today

Godavari Biorefineries LtdQ3 FY25Diversified FMCG

Godavari Biorefineries Ltd Q3 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹256P/E: 29.7Market Cap: ₹1.6K CrSector: Diversified FMCG

Management growth scorecard

Revenue

Category 2

Margin

Category 1

Fundraise

N/A

Order

N/A

Capex

Yes

2 of 3 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→The company anticipates a better sugarcane crushing season from November 2024 to April 2025 due to favorable monsoon and restored ethanol blending program, leading to higher volumes and revenue in H2 FY25.
→Revenue growth was 34% YoY in Q2 FY25 and 25% in H1 FY25 despite seasonality; a stronger performance and improved profitability are expected in H2 FY25 due to crushing season commencement.
→Expansion plans include increasing capacities in biobased specialty chemicals starting Q4 2025, driven by strong global demand and co-creation with customers for decarbonization.
→Investment in grain-based ethanol production will add dual feedstock flexibility, mitigate climate risks, and support growing ethanol blending mandates, potentially boosting volumes and sales.
→Enhanced capacity utilization and debt reduction will free cash flow for growth investments, improving margins and scaling up specialty chemical offerings especially from 2025 onwards.

Margin guidance

Category 1

→Company expects significant improvement in H2 FY25 results due to commencement of sugarcane crushing from November 2024 and restoration of ethanol blending program, leading to higher production and revenue.
→EBITDA and profitability traditionally stronger in H2; last 3 years showed H2 EBITDA over 100% of full-year EBITDA.
→Investment focus on biobased chemicals expansion starting Q4 2025, aiming to improve segment profitability and ROCE.
→Debt reduction via IPO proceeds will save approx. Rs. 24-25 crores annually in interest, freeing cash flow for growth investments.
→Grain-based ethanol facility under planning, expected to give feedstock flexibility and mitigate climate risk, enhancing earnings stability.
→Biobased specialty chemicals segment expected to see stronger demand and capacity ramp-up in H2 FY25, improving margins.
→Overall, optimistic about improved profitability, cash flow, and sustained EPS growth in coming years aligned with expanding product portfolio and green transition.

3 more insights locked — sign up free to unlock

Fundraise plans

- As of March 31, 2024, Godavari Biorefineries had consolidated borrowings of Rs. 663 crores. - The company recently completed an IPO to raise equity capital. - Rs. 240 crores from the IPO proceeds were allocated for full or partial repayment/prepayment of certain borrowings, aimed at reducing debt and interest costs. - The improved debt equity position is intended to free up internal accruals for business growth, especially in biobased chemicals. - There was no mention of new or upcoming fundraising through additional debt or equity beyond the completed IPO and debt repayment plans. - The focus appears to be on utilizing freed-up cash flow from debt reduction to finance expansion and CAPEX, including investments in grain-based ethanol capacity and biobased chemical capacity increases. In summary, no new fundraising through debt or equity is indicated beyond the recent IPO and planned debt repayment.

Order book

→For ethanol bidding under government tenders, Godavari Biorefineries bid for over 10 crore liters but was allotted about 7.5 crore liters (5.4 crore liters for juice-based ethanol and 2.5 crore liters for B-heavy molasses).
→No bids have been placed yet for grain-based ethanol as the company is still in the process of creating that capacity.
→The company expects increased demand for biobased specialty chemicals in the second half of FY25, leading to capacity expansions starting Q4 FY25.
→There is a strong funnel of product development projects with customers for biobased chemicals, with many early-stage molecules in development expected to mature over 3-4 years.
→The crushing season for sugarcane has started recently, and full seasonal production will contribute positively to the order fulfillment and revenue in H2 FY25.

Capex plans

Yes

→The company plans to invest in expanding biobased specialty chemicals capacities, with some capacity increases expected from Q4 2025 onwards.
→There is a strategic focus on developing a grain-based ethanol facility to add dual feedstock capability, providing flexibility and mitigating climate risk.
→Current CAPEX for the grain-based ethanol project is under assessment, with a stronger update expected in the next quarter.
→The IPO proceeds are being used primarily to reduce debt, thereby freeing up internal accruals and cash flow for these growth investments.
→Investments will support participation in India’s ethanol blending program and biobased chemicals market, aligning with the company’s green energy transition strategy.
→The company is investing in research and development, including in biobased chemicals and a cancer drug currently in safety trials.

How does Godavari Biorefineries Ltd rank vs peers in Diversified FMCG?

Pro feature

1Godavari Biorefineries Ltd

Rev 2Mar 1

See full Diversified FMCG sector rankings